(Q34107800)

31 July 2017

1 reference

title

The role of new agents in advanced non-small-cell lung carcinoma (English)

1 reference

31 July 2017

1 reference

ChEBI release 2020-05-28

C J Langer

1

1 reference

31 July 2017

publication date

1 January 2000

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

76-89

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-000-0014-z

31 July 2017

exact match

0 references

cites work

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0014-Z

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0014-Z

Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0014-Z

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0014-Z

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0014-Z

Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion.

21 January 2018

1 reference

12 December 2020

A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer

1 reference

12 December 2020

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.

1 reference

12 December 2020

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

12 December 2020

A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.

1 reference

12 December 2020

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)

1 reference

12 December 2020

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

12 December 2020

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

12 December 2020

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Cytotoxic effects of gemcitabine-containing regimens against human non-small cell lung cancer cell lines which express different levels of p185neu

1 reference

12 December 2020

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

An early phase II study of CPT-11 in primary lung cancer

1 reference

12 December 2020

Clinical Indicators of Prognosis in Unresected Lung Cancer

1 reference

12 December 2020

UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

12 December 2020

Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer

1 reference

12 December 2020

Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung

1 reference

12 December 2020

Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.

1 reference

12 December 2020

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

12 December 2020

UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin

1 reference

12 December 2020

Combination treatment with docetaxel (Taxotere) and platinum compounds for non-small cell lung cancer

1 reference

12 December 2020

Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

12 December 2020

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

1 reference

12 December 2020

Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trials

1 reference

12 December 2020

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer

1 reference

12 December 2020

Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin

1 reference

12 December 2020

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

12 December 2020

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

1 reference

12 December 2020

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

12 December 2020

Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Single-agent paclitaxel in advanced non-small cell lung cancer: single-center phase II study using a 3-hour administration schedule.

1 reference

12 December 2020

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study

1 reference

12 December 2020

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

12 December 2020

Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer

1 reference

12 December 2020

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer

1 reference

12 December 2020

A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial

1 reference

12 December 2020

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

1 reference

12 December 2020

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

12 December 2020

Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

[A phase II study of UFT in non-small cell lung cancer]

1 reference

12 December 2020

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

12 December 2020

Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules

1 reference

12 December 2020

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

1 reference

12 December 2020

Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer. European Lung Cancer Working Party

1 reference

12 December 2020

Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.

1 reference

12 December 2020

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

12 December 2020

Phase I studies of gemcitabine combined with carboplatin or paclitaxel

1 reference

12 December 2020

Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer

1 reference

12 December 2020

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

12 December 2020

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens

1 reference

12 December 2020

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer

1 reference

12 December 2020

Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial.

1 reference

12 December 2020

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

1 reference

12 December 2020

Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.

1 reference

12 December 2020

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study

1 reference

12 December 2020

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1 reference

12 December 2020

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

1 reference

12 December 2020

Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer

1 reference

12 December 2020

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.

1 reference

12 December 2020

Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells

1 reference

12 December 2020

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial

1 reference

12 December 2020

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma

1 reference

12 December 2020

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy

1 reference

12 December 2020

Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer

1 reference

12 December 2020

Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer

1 reference

12 December 2020

10.1007/S11912-000-0014-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1038673572

0 references

1 reference